Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 1Phase 4 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Uterine Cervical Dysplasia 1Neoplasms, Basal Cell 1Keratosis, Actinic 1Carcinoma, Basal Cell 1

Interventions

pembrolizumab 2smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1prednylidene 1methyl 5-aminolevulinate 1gusacitinib 1deltacortene 1Specimen Handling 1Sirolimus 1Prednisone 1Photochemotherapy 1Nivolumab 1Methods 1Magnetic Resonance Spectroscopy 1MAPRE1 protein, human 1Ipilimumab 1Interleukin-2 1HhAntag691 1CTLA-4 Antigen 1Biopsy 1BF-200 ALA 1Arsenic Trioxide 1Aminolevulinic Acid 15-aminolevulinic acid hexyl ester 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Carcinoma, Basal Cell × methyl 5-aminolevulinate × Clear all
NCT02367547 2019-03-28

Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL

Joint Authority for Päijät-Häme Social and Health Care

Phase 1/2 Unknown
117 enrolled
Dermatologic

Carcinoma, Basal Cell, Neoplasms, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡